Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPLF.L Regulatory News (MPLF)

  • There is currently no data for MPLF

Dividend Declaration

2 Jan 2020 17:00

RNS Number : 6127Y
Marble Point Loan Financing Limited
02 January 2020
 

 

2 January 2020

 

Marble Point Loan Financing Limited

Dividend Declaration

Q4 2019 Dividend

The Board of Directors of Marble Point Loan Financing Limited (the "Company") has declared a dividend in respect of the quarter ending 31 December 2019 of $0.025 per ordinary share, which represents an increase of 25 per cent compared to the prior dividend paid on 30 October 2019.

"As described in the Company's November 2019 Monthly Report, quarterly cash distributions per share from the Company's investments in CLO Equity, CLO Debt and other related investments have increased approximately 70 per cent since Q2 2018 and approximately 40 per cent since Q1 2019. Furthermore, the first distribution from our recent investment in Marble Point CLO XVI Ltd. is anticipated to be received during Q1 2020. As such, the Board of Directors of the Company are pleased to announce an increase in the dividend payable to our shareholders of 25 per cent versus the prior quarter. We have increased the annual dividend from $0.08 to $0.10 per share on the timeframe estimated in our 2018 prospectus for our initial public offering, which we believe demonstrates the current cash flow generation capability of our investment portfolio despite the recent volatility in underlying loan prices," said Robert Brown, Chairman of the Company.

The dividend will be payable to the Company's shareholders of record as detailed below:

Dividend:

$0.025 per ordinary share

Ex-Dividend Date:

09 January 2020

Record Date:

10 January 2020

Final Currency Election Date:

13 January 2020

Payment Date:

30 January 2020

The Company declares its cash dividends in U.S. Dollars. Shareholders will, by default, receive their cash dividends in U.S. Dollars. However, the Company has arranged for shareholders to be able to elect to receive cash dividends in Sterling rather than U.S. Dollars. Shareholders who have made an election to receive the dividend in Sterling by the above-referenced Final Currency Election Date will receive the dividend at the prevailing rate at time of currency conversion (as determined by the Company's registrar). No action is required of shareholders who have previously made a dividend currency election or who wish to receive their dividend in U.S. Dollars. The Sterling Dividend Election Information regarding the dividend currency election and Dividend Currency Election Form are available on the Company's website: www.mplflimited.com/investor-relations.

Past performance is not indicative, or a guarantee, of future performance.

This release contains inside information.

ENQUIRES

Marble Point Loan Financing Limited

Investor Relations

Tel.: +44 (0) 20 7259 1500

Email: ir@mplflimited.com

 

Corporate Broker

Stifel Nicolaus Europe Limited

T: +44 (0) 20 7710 7600

 

ABOUT MARBLE POINT LOAN FINANCING LIMITED

Marble Point Loan Financing Limited (the "Company") is a Guernsey closed-ended investment company with its ordinary shares admitted to trading on the Specialist Fund Segment of the Main Market of the London Stock Exchange (tickers: MPLF LN / MPLS LN). The Company is invested in a diversified portfolio of US dollar denominated, broadly syndicated floating rate senior secured corporate loans via CLOs, loan accumulation facilities and other vehicles managed by Marble Point Credit Management LLC or its affiliates. For more information, please visit the Company's website: www.mplflimited.com.

LEI: 549300DWXSN5UC85CL26

IMPORTANT INFORMATION

This document is provided for informational purposes only and does not constitute an offer to sell any shares, notes or other securities (collectively, "Securities") issued by the Company or a solicitation of an offer to purchase any such Securities in the United States, Australia, Canada, the Republic of South Africa, Japan or any other jurisdiction. This document may not be relied upon, and should not be used, for the purpose of making any investment decision. The Securities have not been and will not be registered under the U.S. Securities Act of 1933, as amended, or with any securities regulatory authority of any state or other jurisdiction of the United States and may not be offered or sold in the United States to, or for the account or benefit of, U.S. persons unless they are registered under applicable law or exempt from registration. The Company has not been and will not be registered under the U.S. Investment Company Act of 1940 and investors will not be entitled to the benefits of such Act.

Past performance is not a reliable indicator of current of future results. The value of investments may go down as well as up and investors may not get back any of the amount invested. The value of investments designated in another currency may rise and fall due to exchange rate fluctuations in respect of the relevant currencies. Adverse movements in currency exchange rates can result in a decrease in return and a loss of capital.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DIVEAKFAESNEEFA
Date   Source Headline
21st Jul 20236:00 pmRNSDividend Declaration
20th Jul 20237:00 amRNSNet Asset Value & Publication of Monthly Report
29th Jun 20237:00 amRNSDividend Declaration
26th Jun 20236:02 pmRNS1st Quarter Results
23rd Jun 20235:30 pmRNSAnnouncement of Corporate Actions
23rd Jun 20237:00 amRNSNet Asset Value & Publication of Monthly Report
19th May 20231:36 pmRNSRevolving Credit Facility Extension
19th May 20237:00 amRNSNet Asset Value & Publication of Monthly Report
15th May 20234:31 pmRNSDistribution Announcement
24th Apr 20235:30 pmRNSSterling Dividend Amount
21st Apr 20235:00 pmRNSNet Asset Value & Publication of Monthly Report
12th Apr 20236:00 pmRNSAnnual Financial Report
11th Apr 20234:10 pmRNSHolding(s) in Company
30th Mar 20234:10 pmRNSDividend Declaration
23rd Mar 20237:00 amRNSNet Asset Value & Publication of Monthly Report
22nd Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Feb 20237:00 amRNSLiquidating Share Class Distribution Announcement
22nd Feb 20237:00 amRNSNet Asset Value & Publication of Monthly Report
30th Jan 20237:00 amRNSHolding(s) in Company
23rd Jan 20237:00 amRNSNet Asset Value & Publication of Monthly Report
19th Jan 20236:00 pmRNSDividend Declaration
12th Jan 20236:17 pmRNSMPLF Director / PDMR Shareholding
12th Jan 20236:00 pmRNSCompany Investment Manager Acquired by Investcorp
10th Jan 20236:00 pmRNSHolding(s) in Company
28th Dec 20226:00 pmRNSDividend Declaration
22nd Dec 20226:30 pmRNSNotice of Ordinary Share Re-designation
22nd Dec 20226:30 pmRNSChanges to the Board of Directors
21st Dec 20226:30 pmRNSNet Asset Value & Publication of Monthly Report
2nd Dec 20227:30 amRNSCompany Investment Manager Agrees to Combination
22nd Nov 20226:00 pmRNS3rd Quarter Results
22nd Nov 20227:00 amRNSNet Asset Value & Publication of Monthly Report
17th Nov 20227:00 amRNSResults of General Meeting
17th Nov 20227:00 amRNSResults of Annual General Meeting
26th Oct 20227:00 amRNSNotice of Annual General Meeting
25th Oct 20227:00 amRNSNet Asset Value & Publication of Monthly Report
21st Oct 20226:00 pmRNSSterling Dividend Amount
29th Sep 20227:00 amRNSDividend Declaration
21st Sep 20227:00 amRNSNet Asset Value & Publication of Monthly Report
13th Sep 20226:00 pmRNSHalf-Year Report
19th Aug 20227:00 amRNSNet Asset Value & Publication of Monthly Report
26th Jul 20227:00 amRNSIssue of Equity
22nd Jul 20226:30 pmRNSNet Asset Value & Publication of Monthly Report
21st Jul 20226:00 pmRNSDividend Declaration
15th Jul 20227:00 amRNSPublication of Key Investor Document
30th Jun 20227:00 amRNSDividend Declaration
23rd Jun 20227:00 amRNSNet Asset Value & Publication of Monthly Report
23rd Jun 20227:00 amRNSTotal Voting Rights
20th Jun 20227:00 amRNSDirector/PDMR Shareholding
16th Jun 20225:32 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.